Clinical Outcomes of Palliative Surgery Including a Systemic-to-Pulmonary Artery Shunt in Infants With Cyanotic Congenital Heart Disease
Author(s) -
Jennifer S. Li,
Eric Yow,
Katherine Berezny,
John F. Rhodes,
Paula M. Bokesch,
John R. Charpie,
Geoffrey A. Forbus,
Lynn Mahony,
Lynn Boshkov,
Virginie Lambert,
Damien Bonnet,
Ina MichelBehnke,
T.P. Graham,
Masato Takahashi,
James Jaggers,
Robert M. Califf,
Amit Rakhit,
Sylvie Fontecave,
Stephen P. Sanders
Publication year - 2007
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.106.652172
Subject(s) - medicine , hazard ratio , tetralogy of fallot , surgery , cardiology , heart disease , proportional hazards model , pulmonary atresia , confidence interval
Aspirin (ASA) often is used to prevent thrombosis in infants with congenital heart disease after placement of a systemic-to-pulmonary artery shunt, but its effect on outcomes is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom